Substance / Medication

Gonadotropin releasing factor

Overview

Active Ingredient
gonadorelin
RxNorm CUI
6384

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Short- and Long-Term Complications of Intraoperative Benign Ovarian Cyst Spillage: A Systematic Review and Meta-analysis.
Eisenberg Neta, Volodarsky-Perel Alexander, Brochu Ian et al. · J Minim Invasive Gynecol · 2021
PMID: 33279627Meta-Analysis
Association of phthalate exposure with precocious and delayed pubertal timing in girls and boys: a systematic review and meta-analysis.
Golestanzadeh Mohsen, Riahi Roya, Kelishadi Roya · Environ Sci Process Impacts · 2020
PMID: 32091510Meta-Analysis
Prevalence and pathogenesis of osteopenia and osteoporosis in epidermolysis bullosa: An evidence-based review.
Chen Jessica Szu-Chia, Yang Anes, Murrell Dédée F · Exp Dermatol · 2019
PMID: 30118182Meta-Analysis
Brain and Cognitive Development in Adolescents with Anorexia Nervosa: A Systematic Review of fMRI Studies.
Olivo Gaia, Gaudio Santino, Schiöth Helgi B · Nutrients · 2019
PMID: 31443192Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Gonadotropin releasing factor (substance)
SNOMED CT
49869009
UMLS CUI
C0023610
RxNorm CUI
6384

Clinical Data

This intervention maps to 4 entities in the Healos knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.